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Research
Breast milk is widely recognized as the best
source of nourishment for infants (Gartner
et al. 2005). Breast-feeding also fosters an
infant’s emotional and social well-being (Else-
Quest et al. 2003; Winberg 2005). The
American Academy of Pediatrics (Gartner
et al. 2005), World Health Organization
(WHO 2001), and the International Council
of Nurses (ICN 2006) all recommend that
infants be exclusively breast-fed for the ﬁrst 6
months of life. It is important that milk be as
free of detrimental agents as possible (LaKind
et al. 2004); it is also important that the
maternal diet provides the nutrients needed
for high milk quality (Dorea 2002). This is
especially true for iodine. Iodine deﬁciency is
widely recognized as the leading and most
readily preventable cause of mental impair-
ment in children (Delange et al. 2001).
Unlike adults, neonates do not have signifi-
cant thyroxine stores (van den Hove et al.
1999). Exclusively breast-fed infants depend
on their mother’s milk iodine for thyroid hor-
mone (TH) synthesis and establishment of
TH stores from which they can draw TH if
iodine availability falls.
Thyroid hormones and therefore iodine
are essential to fetal and infant neurodevelop-
ment. Infants born to hypothyroid- or iodine-
deficient women exhibit intellectual and
behavioral deficits as children (Rovet and
Ehrlich 2000). Such deﬁcits may be apparent
in infants as young as 3 weeks even if the
degree of early deficiency was small or tran-
sient or occurred during fetal development
(Kooistra et al. 2006). The Institute of
Medicine (IOM 2001) recommends an iodine
intake of 110 μg/day for infants 0–6 months of
age, and 130 μg/day for infants 7–12 months
of age. Iodine needs of pre-term infants may be
twice what is needed by full-term infants
(Ares et al. 2005). Breast milk–iodine content
is considered sufficient when levels are
150–180 μg/L (Delange 2004). Milk samples
provided by most women in our previous
study (Kirk et al. 2005) fell far short of this
standard. The median iodide level in human
milk from 23 donors residing in 15 different
states (Kirk et al. 2005) was 33.5 μg/L, and
only 4 samples fell within the recommended
level. We have therefore been concerned that
lactating women in the United States may not
be consuming sufficient iodine to meet the
needs of their breast-fed infants. 
Exposure to perchlorate and other iodide
transport inhibitors may increase the risk
of iodine deficiency among infants. The
sodium–iodide symporter (NIS) is 30-fold
more selective for perchlorate than for iodide
and is reportedly 9–100 times as potent as
thiocyanate in inhibiting iodide uptake
(Dohan et al. 2003; Tonacchera et al. 2004).
Perchlorate and other iodide transport
inhibitors such as thiocyanate thus likely
reduce transfer of iodide to breast milk at the
mammary NIS. Unless major dietary changes
have occurred after the birth of her child, it is
also likely that a woman with perchlorate
and/or thiocyanate in her milk was similarly
exposed during pregnancy, potentially reduc-
ing the pool of maternal TH needed for fetal
development and reducing the ability of the
fetal thyroid to produce its own hormones. For
a nursing infant, the production of TH would
be dually impaired: ﬁrst by reduction of breast-
milk iodide content and then by reduced
iodide uptake by the infant thyroid. A discrimi-
nation factor of 30× at both stages amounts to
3 orders of magnitude of discrimination over-
all. Various aspects of brain development
depend precisely on when TH deficiency
occurs. An infant who had insufficient TH
during fetal life might suffer delay or impair-
ment in neurologic functions that develop
in utero. This infant may suffer other impair-
ments if TH deﬁciency occurs again, or con-
tinues, after parturition. Transient or mild
hypothyroidism during fetal or infant develop-
ment may result in long-standing, possibly
permanent functional deficits that include
learning disabilities and hyperactivity
(Haddow et al. 1999; Morreale de Escobar
et al. 2000; Rovet 2002, 2005; Pop et al.
1999). Some ﬁnd strong links between iodine
deficiency and attention deficit disorders
(ADD; Vermiglio et al. 2004). In the United
States, an estimated 3–5% of children (approx-
imately 2 million) have ADD (National
Institute of Mental Health 2003). 
A lack of data on the variability of iodide
excretion limits our ability to assess milk
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BACKGROUND: Perchlorate and thiocyanate interfere with iodide uptake at the sodium–iodide
symporter and are potential disruptors of thyroid hormone synthesis. Perchlorate is a common
contaminant of water, food, and human milk. Although it is known that iodide undergoes signiﬁ-
cant diurnal variations in serum and urinary excretion, less is known about diurnal variations of
milk iodide levels. 
OBJECTIVES: Variability in perchlorate and thiocyanate excretion in human milk has not been
examined. Our objective was to determine variability of perchlorate, thiocyanate, and iodide in seri-
ally collected samples of human milk. 
METHODS: Ten lactating women were asked to collect six milk samples on each of 3 days. As an
alternative, subjects were asked to collect as many milk samples as comfortably possible over 3 days.
Samples were analyzed for perchlorate, iodide, and thiocyanate by ion chromatography coupled
with mass spectrometry. 
RESULTS: Individual perchlorate, iodide, and thiocyanate levels varied signiﬁcantly over time; there
was also considerable variation among individuals. The iodide range, mean ± SD, and median for
all samples (n = 108) were 3.1–334 µg/L, 87.9 ± 80.9 µg/L, and 55.2 µg/L, respectively. The range,
mean ± SD, and median of perchlorate in all samples (n = 147) were 0.5–39.5 µg/L, 5.8 ± 6.2 µg/L,
and 4.0 µg/L. The range, mean ± SD, and median of thiocyanate in all samples (n = 117) were 0.4
–228.3 µg/L, 35.6 ± 57.9 µg/L, and 5.6 µg/L. The data are not symmetrically distributed; the mean
is higher than the median in all cases. 
CONCLUSIONS: Iodine intake may be inadequate in a signiﬁcant fraction of this study population.
Perchlorate and thiocyanate appear to be common in human milk. The role of these chemicals in
reducing breast milk iodide is in need of further investigation. 
KEY WORDS: breast-feeding, human milk iodide, milk, perchlorate, thiocyanate. Environ Health
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20 November 2006]iodine levels. Most studies of human milk
iodide, including our own, have been based on
single samples (Ciardelli et al. 2002; Skeaff
et al. 2005), although a few have examined
iodide content in samples from two (Gushurst
et al. 1984; Moon and Kim 1999) or three
points in time (Chierici et al. 1999). These
measures may not accurately portray infant
intake, especially if samples were systematically
collected at times when iodide content is low.
The same holds for perchlorate in milk.
Although perchlorate may be common in
human milk, nothing is known about the
temporal variation of perchlorate levels.
Finally, thiocyanate, a by-product of cyanide
metabolism, is also found in human milk. We
describe the variation of iodide, perchlorate,
and thiocyanate levels in series of human milk
samples. The implications for infant develop-
ment are discussed.
Materials and Methods
Ten lactating subjects were recruited and gave
informed consent under a protocol approved
by the Texas Tech University Institutional
Review Board. Subjects were provided with
precleaned 50-mL polypropylene tubes
(Fisher Scientific, Fairlawn, NJ). Half the
subjects were from the Texas Panhandle. One
subject each was from Colorado, Florida,
Missouri, New Mexico, and North Carolina.
None reported being smokers or being vege-
tarian. All subjects were of European descent
except for one woman residing in Texas who
is of West African origin. Subjects were
recruited through public notices and by word
of mouth (subjects from previous studies,
friends/associates of present and previous sub-
jects). Subjects were of mid- to high socioeco-
nomic status. Pregnant women were excluded
from the study. All subjects reside in small
cities or suburban environments except for
one subject who resides in a small agricultural
community. Samples were either expressed by
pump and transferred from collection bags
into provided collection tubes, or expressed
manually directly into polypropylene tubes.
After expression, sample tubes were placed in
a supplied plastic container and stored in the
donor’s home freezer until transferred to our
facility, where they were maintained at
–20°C. Samples were thawed before process-
ing at 1°C. Each subject was asked to provide
six samples on each of 3 days. Alternatively,
subjects were asked to provide as many sam-
ples of breast milk as comfortably possible
over a series of days. 
Subjects provided between six and 18
samples over an average of 4.4 days (range,
2–14 days). Days were not required to be
consecutive so that inconvenience to subjects
could be minimized. Subjects were asked to
record dates and times of sample collections
and everything they ate or drank during the
days that samples were collected. Food con-
sumption was evaluated using the U.S.
Department of Agriculture’s (USDA) food
group tracking program “MyPyramid
Tracker” (USDA 2006) and correlated with
levels of perchlorate, thiocyanate, and iodide
in milk. Samples were processed and analyzed
by ion chromatography–mass spectrometry
according to the method reported by Dyke
et al. (2006). 
Results
We found considerable variability in perchlo-
rate, iodide, and thiocyanate excretion both
within and among individuals. The iodide
range, mean ± SD, and median for all samples
(n = 108) were 3.1–334 μg/L, 87.9 ± 80.9
μg/L, and 55.2 μg/L respectively. The range,
mean ± SD, and median of perchlorate in all
samples (n = 147) was 0.5–39.5 μg/L, 5.8 ±
6.2 μg/L, and 4.0 μg/L. Range, mean ± SD,
and median of thiocyanate in all samples (n =
117) was 0.4–228.3 μg/L, 35.6 ± 57.9 μg/L,
and 5.6 μg/L. The data, based on the mean
and variance, are skewed to the right. Median,
rather than mean, values are therefore the pre-
ferred measure for the data set as a whole.
Means and variance for individuals are
reported in Table 1. 
On eight occasions a subject collected
milk samples before consuming any food or
liquid in the morning. These were matched
with a sample collected after the subject’s
evening meal. Student’s t-test demonstrated a
significant increase in perchlorate levels
between prebreakfast and postdinner samples
(p < 0.03). No statistically significant differ-
ence was found for iodide or thiocyanate levels
in these samples. 
Milk iodine levels < 50 μg/L are consid-
ered “consistent with iodine deficiency”
(Bazrafshan et al. 2005). Nearly half (46%) of
all milk samples tested were below this thresh-
old. Only 23% of the samples tested met the
iodide sufficiency definition of Delange
(2004). Only two of 10 donors had mean
iodide levels that met the standard of iodide
sufficiency when iodide concentrations were
averaged. One of these subjects (C) took an
iodine-containing supplement. Interestingly,
samples from the other iodine-sufficient
woman (E) also had the highest mean levels of
perchlorate (21.4 ± 11.9 μg/L) and thio-
cyanate (149.6 ± 19.8 μg/L). Results for indi-
vidual subjects are summarized in Table 1. 
One subject reported exclusively using bot-
tled spring water. The drinking water for two
subjects came from a reverse osmosis–treated
source; perchlorate levels in milk samples from
these subjects were higher than the mean, with
samples from one of the two volunteers (E)
having the highest perchlorate content of all
samples submitted (mean 21.4 μg/L, n = 10).
Perchlorate in milk samples of the other sub-
ject drinking reverse osmosis–treated water (I)
was also well above the median of 4.0 μg/L. 
Perchlorate levels exceeded those of thio-
cyanate in 41% of the samples submitted.
There was one sample each from two individ-
uals in which perchlorate levels exceeded
those of iodide. The iodide:perchlorate molar
ratio ranged from 0.55 to 130 with a mean ±
SD of 18.5 ± 21.9 and a median of 13.3. The
thiocyanate:perchlorate molar ratio ranged
from 0.016 to 267. The mean ± SD thio-
cyanate:perchlorate molar ratio was 18.2 ±
43.1, and the median value was 2.0. The
iodide:thiocyanate molar ratio ranged from
0.21 to 251 with a mean ± SD of 33.4 ± 60.2
and a median of 3.0.
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Table 1. Donor food intake and mean perchlorate, iodide, and thiocyanate in breast milk.
No. of Iodide Perchlorate Thiocyanate 
Donor Days Samples Vegetable Fruit Grain Milk Meat/bean (mean ± SD) (mean ± SD) (mean ± SD)
A 2 11 78 13 114 129 67 123.6 ± 107.0 2.1 ± 0.5 96.0 ± 44.2
B 4 16 62 76 73 81 119 58.9 ± 25.6 3.8 ± 2.1 7.0 ± 9.9
C 14 18 66 26 116 54 55 201.2 ± 49.7 5.5 ± 1.3 15.4 ± 53.2
D 2 11 62 77 91 15 171 24.4 ± 7.2 7.6 ± 4.7 8.6 ± 7.0
Ea 2 8 67 118 120 55 104 182.2 ± 55.2 21.4 ± 11.9 149.6 ± 19.8
F 3 14 72 2 166 54 55 12.0 ± 7.2 1.4 ± 0.7 0.8 ± 0.5
G 3 16 28 118 64 70 43 43.5 ± 25.6 4.2 ± 3.2 3.7 ± 11.2
H 3 6 16 35 78 32 89 119.4 ± 29.8 4.4 ± 3.9 160.5 ± 42.0
Ia 3 10 127 85 39 33 94 49.3 ± 22.8 7.3 ± 5.0 31.2 ± 16.1
J 4 6 NA NA NA NA NA NA 6.2 ± 2.5 15.2 ± 9.4
NA, not available; data were lost through instrument malfunction, and sufﬁcient sample for a rerun was not available. Data on food intake are reported as percentage of recommended
intake by the USDA (2006).
aSubject uses reverse osmosis water. Only one subject (C) reported taking an
iodine-containing nutritional supplement.
Figure 1 shows iodide data for samples from
this subject along with data from a subject (B)
not taking an iodine-containing supplement
whose median iodide values was closest to the
median iodide value for the entire cohort.
The difference in milk iodide content is read-
ily noticeable. Temporal variability in iodide,
perchlorate, and thiocyanate levels for all sub-
jects are shown in Figure 2A–C. 
The Centers for Disease Control and
Prevention (CDC) recommend that women
consume 5–9 servings of fruit and vegetables
daily (CDC 2006a). Only two of our
donors met this recommendation (Table 1).
Perchlorate levels were positively correlated
(r2 = 0.5589) with consumption of fruit and
vegetables. Iodide and thiocyanate milk levels
were not correlated with intake of fruit and
vegetables. The unexpected lack of correlation
between thiocyanate in milk and fruit/
vegetable intake may be explained by high
intake of soy-based nutritional supplements
along with low produce intake by one subject.
When data from this and another subject
with unexpectedly high thiocyanate levels are
removed, the correlation increases from near
zero to an r2 = 0.4758. 
One donor (H) had particularly high
thiocyanate levels (individual mean = 160.5
μg/L, individual median = 165.3 μg/L) when
her data were compared with data from all
other subjects (mean = 28.9g/L, median
5.2 μg/L) despite having the lowest level of
produce intake. Although it is possible that
this donor was exposed to cigarette smoke
either actively or passively, she was the only
subject who used soy-based nutritional bever-
ages (mean daily intake 460 mL).
Discussion
For breast-fed infants < 12 months of age,
average milk consumption is 100 mL/kg/day
(Arcus-Arth et al. 2005). Three of our 10 sub-
jects had average breast-milk perchlorate con-
centrations > 7 μg/L; thus for the infants of
these mothers, the National Research Council
(NRC) reference dose for perchlorate at
0.7 μg/kg/day (NRC 2005) will be exceeded.
A more detailed analysis of breastmilk con-
sumption as a function of age (Arcus-Arth
et al. 2005), however, indicates that exposure
per unit weight declines with age. Average
milk intake as a function of age is available in
studies by Butte et al. (1984) and Neville
et al. (1988). Average infant weight as a func-
tion of age is available from the CDC
(2006b); these are divided by sex—an average
was used here—and the difference between
the sexes is very slight. This information has
been combined with our breast-milk concen-
tration data to generate Figure 3, which
shows iodide, perchlorate, and thiocyanate
intake in micrograms per kilogram per day for
an average-weight infant as a function of age.
Each plot further shows three traces; each
shows the intake of hypothetical infants con-
suming the mean, median, and the highest
level of each species. (The mean, median, and
highest values pertain to averaged data for
each individual as listed in Table 1.) Figure
3A reveals that based on the median iodide
content, iodine intake of our test infant popu-
lation is substantially below the recom-
mended level of 110–130 μg/day. Figure 3B
indicates that if an infant of average weight,
consuming an average quantity of breast milk,
has a perchlorate intake corresponding to the
median perchlorate content in this study, the
NRC reference dose of 0.7 μg/kg/day (NRC
2005) will be exceeded for the ﬁrst 2 months
of his or her life. Figure 3C indicates that if
perchlorate is indeed an order of magnitude
or so more potent than thiocyanate in its
power to inhibit iodide transport, the relative
contribution of thiocyanate to iodine trans-
port inhibition in an infant is small compared
with that of perchlorate, where the infant
consumes the median concentration of per-
chlorate and the median concentration of
thiocyanate, within the limits of this study.
Single-membrane reverse-osmosis systems
typically remove 80% of the perchlorate
Kirk et al.
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Figure 1. Iodide content of milk samples from two
subjects (B, C). One has been taking an iodide
supplement. 
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Figure 2. Temporal patterns for (A) iodide, (B) perchlorate, and (C) thiocyanate levels in human milk sam-
ples. Individual subjects are represented by symbols noted in key. 
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Hpresent (Foster Wheeler Environmental
Corporation 1999). The fact that higher lev-
els of perchlorate were present in milk sam-
ples from subjects drinking water treated by
reverse osmosis indicates that drinking water
is not necessarily the principal vector for per-
chlorate exposure. Moreover, one of these
participants (E) used a reverse-osmosis system
connected to a municipal water supply, which
we have repeatedly analyzed: The perchlorate
concentration in the feed water ranged from 0
to 4 μg/L, with rare excursions > 2 μg/L.
Clearly, her perchlorate intake through drink-
ing water would not account for the observed
expression in breast milk. This fact—that
drinking water is not generally an important
vector for perchlorate exposure—is consistent
with measurements of urinary perchlorate
versus drinking-water perchlorate reported by
Valentin-Blasini et al. (2005). 
The signiﬁcant difference found between
prebreakfast and postdinner perchlorate levels
was not surprising, given its relatively short
8-hr half-clearance time in humans (Greer
et al. 2002). Thiocyanate is thought to have a
half-life of 1–6 days (Junge 1985; Schulz et al.
1979), and its excretion in milk is expected to
be more stable over time. 
If overall intake of iodide is sufﬁcient, it is
unlikely that milk with an occasional low
iodide or high perchlorate content would pose
a major risk to infants. However, the data pre-
sented here, admittedly limited, indicate that
the milk of many women may not supply
infants with adequate iodide, while the infants
are also being exposed to signiﬁcant levels of
perchlorate. Such infants may be at risk of
altered neurologic development due to iodine
deficiency with exposure to iodide-uptake
inhibitors posing an additional burden. We did
not measure urinary iodine content of the sub-
jects; this, together with breast milk iodine
expression, would have allowed us an estimate
of the overall iodine intake of the individual.
The question as to whether milk iodide is low
because of iodide-uptake inhibitors such as
perchlorate and thiocyanate, or whether iodide
levels are low simply because maternal intake is
low, cannot be answered at present without the
urinary data. It may be more important to base
risk assessment for perchlorate exposure on the
iodide:perchlorate ratio, or the ratio of iodide
to “selectivity-weighted sum of iodide uptake
inhibiting agents.” If perchlorate uptake occurs
30 times more readily at the NIS in vivo as it
appears to in vitro (Tonacherra et al. 2004),
then an infant drinking milk with a ratio of
30:1 iodide:perchlorate may have an uptake
ratio of 50:50 at its thyroid. If infants are able
to use only half the iodide they receive in
breast milk, potential iodine deficiency is a
concern. For some individuals these ratios are
relatively invariant on an order of magnitude
scale, whereas wide variation is seen in others.
The geometric mean of all the iodide:perchlo-
rate molar ratio values is approximately 11. If
the literature value for the in vitro results for
iodide transport inhibition by perchlorate is
applicable in vivo, then perchlorate may indeed
be having a measurable effect on iodide trans-
port. Similarly, the geometric mean of the
iodide:thiocyanate and thiocyanate:perchlorate
molar ratios are approximately 4.9 and 2.3,
respectively, suggesting again that the effects of
thiocyanate on iodide transport inhibition is
less important than that of perchlorate in our
sample population. 
The real role, if any, of perchlorate in
reduction of milk iodide levels is as yet
unknown. Although there is evidence of inhibi-
tion from mathematical modeling (Almström
2006), this issue may be best examined
through a controlled animal study; for a
human study, at least simultaneous urinary
data are needed to judge how intake affects
expression. Our subjects had highly varied
diets and varied timing of food intake; some
used nutritional supplements and some did
not. To further complicate correlations
among analytes, the timing of milk sample
collection was not uniform among donors or
among days of individuals. The thyroid gland
is adaptable and NIS expression increases
when TH levels fall (Levy et al. 1997). NIS
expression in the mammary gland is increased
in response to prolactin, oxytocin, and
β-estradiol (Tazebay et al. 2000), but it is not
known whether mammary NIS is responsive
to TSH (or some other signal) in a manner
that would enable it to compensate for
the presence of iodide-uptake inhibitors.
Unfortunately, the degree to which the infant
thyroid may be able cope with iodide-uptake
inhibitors is also unknown. 
Little is known about thiocyanate in
human milk. To our knowledge, this is the
ﬁrst report of thiocyanate content of human
milk in serial samples. Work was done on
Perchlorate, thiocyanate, and iodide excretion in human milk
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Figure 3. Projected iodide (A), perchlorate (B), and thiocyanate (C) intake of infants as a function of age
corresponding to median, mean, and highest average values of each species in the sample population.
See text for details. 
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thiocyanate excretion in human, bovine, and
rat milk during the 1960s (Funderburk and
Van Middlesworth 1967). These researchers
also reported that dosing rats with perchlorate
reduces thiocyanate excretion in milk.
Laurberg et al. (2004) reported that maternal
serum thiocyanate levels are strongly corre-
lated with low milk iodide levels. Cassava, a
staple food in some African regions, contains
high levels of thiocyanate and may contribute
to iodine deﬁciency. Mean thiocyanate levels
in human milk from a region of northern
Zaire, where cassava consumption is high,
were reported at 513 μg/L (Vanderpas et al.
1984). The highest level of thiocyanate
detected in our study was less than half this
amount (228.3 μg/L). The mean for our
cohort was approximately 6% of the mean
calculated for the northern Zaire cohort.
The present research supports earlier ﬁnd-
ings that perchlorate is common, if not ubiq-
uitous, in the milk of U.S. women. Little
information has been available on the variabil-
ity of perchlorate levels in milk in individuals.
This lack of information has made it difﬁcult
to assess infant exposures. An apparent insufﬁ-
ciency of iodine in human milk is cause for
concern. U.S. infants may be at risk of iodine
deficiency. Whether such risk originates in
dietary insufﬁciency or in exposure to iodide
uptake inhibitors or both is not currently
known. Although removal of perchlorate or
other iodide transport inhibitors from U.S.
food and water supplies may be a laudable
goal, this does not appear to be imminent. An
effort to phase in better iodine nutrition seems
warranted. 
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